Pioneering RNA Cell Therapy for
Pioneering RNA Cell Therapy for autoimmune diseases
Our Commitment to our Patients
We are committed to developing potent yet safer cell therapies for patients with autoimmune diseases.
Our therapeutic candidates
We are conducting clinical trials in patients with autoimmune diseases.
We are an integrated team of physicians and scientists working to develop the safest, most effective RNA cell therapies for our patients.
Stay up to date on Cartesian
– Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesian’s wholly owned pipeline…